Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.

D S Charney , S W Woods
The Journal of Clinical Psychiatry 50 ( 11) 418 -423

56
1989
Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.

F A Hameedi , M J Kreek , T J McMahon , T R Kosten
Journal of Pharmacology and Experimental Therapeutics 276 ( 3) 1128 -1135

39
1996
A review of behavioral and pharmacologic studies relevant to the application of CO2 as a human subject model of anxiety.

J H Krystal , D S Charney , C L D'Amico , G R Heninger
Psychopharmacology Bulletin 24 ( 1) 149 -153

8
1988
Postpartum onset of panic disorder: a coincidental event?

D E Sholomskas , S W Woods , P J Wickamaratne , D W O'Brien
The Journal of Clinical Psychiatry 54 ( 12) 476 -480

41
1993
Insights into psychosis risk from leukocyte microRNA expression

C D Jeffries , D O Perkins , S D Chandler , T Stark
Translational Psychiatry 6 ( 12)

12
2016
REGIONAL CEREBRAL BLOOD FLOW CHANGES IN PATIENTS WITH PANIC DISORDER

K Koster , S W Woods , E O Smith , I G Zubal
Clinical Nuclear Medicine 14 ( 3) 234

1989
A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan

J Gelernter , G P Page , K Bonvicini , S W Woods
Molecular Psychiatry 8 ( 1) 71 -82

50
2003
Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs.

J. H. Krystal , L. H. Price , W. K. Goodman , D. S. Charney
The Journal of Clinical Psychiatry 51 44 -46

81
1990
The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients

D. S. Charney , S. W. Woods , P. L. Delgado , G. R. Heninger
The Journal of Clinical Psychiatry 51 ( 12) 505 -507

18
1990
PANIC DISORDER AND PREGNANCY. REPLY

D. E. Sholomskas , S. W. Woods , J. Benjamin , P. J. Wickamaratne
The Journal of Clinical Psychiatry 56 ( 1)

1995
Noradrenergic dysregulation in panic disorder

W. M. Glazer , L. H. Price , W. K. Goodman , D. S. Charney
Frontiers of clinical neuroscience 8 91 -105

29
1990
Biologic responses to panic anxiety elicited by nonpharmacologic means

D. S. Scharney , S. W. Woods
Frontiers of clinical neuroscience 8 205 -217

4
1990
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample

K. S. Cadenhead , R. E. Carrión , J. Addington , C. E. Bearden
Acta Psychiatrica Scandinavica 132 ( 1) 60 -68

29
2015
Does hallucination perceptual modality impact psychosis risk

H. F. Niles , B. C. Walsh , S. W. Woods , A. R. Powers
Acta Psychiatrica Scandinavica 140 ( 4) 360 -370

4
2019
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method

S. Leucht , M. Samara , S. Heres , M. X. Patel
Schizophrenia Bulletin 40 ( 2) 314 -326

312
2014
Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients

D. S. Charney , S. W. Woods , J. H. Krystal , L. M. Nagy
Acta Psychiatrica Scandinavica 86 ( 4) 273 -282

200
1992
Pre-onset Detection and Intervention Research in Schizophrenia Psychoses: Current Estimates of Benefit and Risk

T. H. McGlashan , T. J. Miller , S. W. Woods
Schizophrenia Bulletin 27 ( 4) 563 -570

117
2001